Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 18;7(6):69.
doi: 10.3390/brainsci7060069.

Contribution of the Degeneration of the Neuro-Axonal Unit to the Pathogenesis of Multiple Sclerosis

Affiliations
Review

Contribution of the Degeneration of the Neuro-Axonal Unit to the Pathogenesis of Multiple Sclerosis

Hannah E Salapa et al. Brain Sci. .

Abstract

Multiple sclerosis (MS) is a demyelinating, autoimmune disease of the central nervous system. In recent years, it has become more evident that neurodegeneration, including neuronal damage and axonal injury, underlies permanent disability in MS. This manuscript reviews some of the mechanisms that could be responsible for neurodegeneration and axonal damage in MS and highlights the potential role that dysfunctional heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and antibodies to hnRNP A1 may play in MS pathogenesis.

Keywords: RNA binding protein; axonal damage; hnRNP A1; multiple sclerosis; neurodegeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Axonal Damage in multiple sclerosis (MS). (1) In a normal, healthy axon, myelin (blue) wraps around the axon and ion channels (orange) are clustered in the unmyelinated nodes of Ranvier. This enables saltatory conduction for fast signal transmission down the axon. RNA binding proteins, which maintain RNA homeostasis, are localized to the nucleus (red). Mitochondria and other cargo (green circles) are transported retrogradely along the axon by dynein (turquoise squares, inset) while anterograde transport is done by kinesin motor proteins (yellow circles, inset). Transport is fast and uninterrupted because the axon is undamaged, has no energy shortage, and the motor proteins are intact; (2) In MS, there is central nervous system infiltration of T-cells, B-cells, plasma cells, and macrophages, which lead to a cascade of events including the release of pro-inflammatory cytokines and antibodies, which are thought to be harmful to both myelin and neurons and axons. [43,44,45,46,47,48,49]; (3) Axonal damage and neurodegeneration occur simultaneously with inflammation. There is ongoing demyelination due to antibodies against myelin antigens (blue Y, A) [43,44,45]. Demyelination leads to the redistribution of ion channels (B), which impairs conduction along the axon [32,33]. The redistribution of RNA binding proteins from their normal nuclear location (panel 1, red) to the cytoplasm (panel 3, C, red) is a pathological feature of neuronal degeneration in neurological diseases [25,26,27,28,30,31]. Mutations in mitochondrial DNA (D) can impair the cell’s ability to generate enough ATP while antibodies to non-myelin antigens (black Y, E) damage axons [46,47,48,49]. Reactive oxygen species (yellow, F) could be released from activated microglia or as a result of dysfunctional mitochondria [37,38,39,40,41]. Impaired fast axonal transport (G) is also evident in MS [9,34,35,36]. A combination of these events, as opposed to one in particular, contributes to neurodegeneration and axonal damage in MS.

References

    1. Lassmann H., Brück W., Lucchinetti C.F. The immunopathology of multiple sclerosis: An overview. Brain Pathol. 2007;17:210–218. doi: 10.1111/j.1750-3639.2007.00064.x. - DOI - PMC - PubMed
    1. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000;343:938–952. doi: 10.1056/NEJM200009283431307. - DOI - PubMed
    1. Levin M.C., Lee S., Gardner L.A., Shin Y., Douglas J.N., Groover C.J. Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease. Degener. Neurol. Neuromuscul. Dis. 2012;2:175–187. doi: 10.2147/DNND.S38353. - DOI - PMC - PubMed
    1. Milo R., Miller A. Revised diagnostic criteria of multiple sclerosis. Autoimmun. Rev. 2014;13:518–524. doi: 10.1016/j.autrev.2014.01.012. - DOI - PubMed
    1. Confavreux C., Vukusic S., Moreau T., Adeleine P. Relapses and progression of disability in multiple sclerosis. N. Engl. J. Med. 2000;343:1430–1438. doi: 10.1056/NEJM200011163432001. - DOI - PubMed

LinkOut - more resources